COMPASS THERAPEUTICS INC
Public company snapshot, recent ticker-linked headlines, and a path into evidence-backed AI research.
Latest price
$0.79
+4.01%
Alpha Vantage · 10/30/2026
One-year price history
Adjusted daily closes · 252 observations · as of Oct 30, 2026
1 month
-12.8%
3 months
-58.3%
6 months
-59.9%
1 year
-78.9%
Year to date
-85.4%
52-week range
$0.75 – $6.69
Fundamental snapshot
Latest reported period: Jun 30, 2026
Market cap
$141.5M
P/E
-1.9
P/B
0.9
P/S
—
Revenue
$0
Net income
-$73.45M
Diluted EPS
-0.39
Gross margin
—
Net margin
—
Return on equity
-38.70%
Total debt
$9.63M
Cash
$36.02M
Free cash flow
-$56.38M
Latest eight reported quarters
Reported quarterly values, newest first
| Period | Revenue | Net income | Gross margin | Net margin | Free cash flow |
|---|---|---|---|---|---|
| Jun 30, 2026 | $0 | -$25.15M | — | — | -$14.91M |
| Mar 31, 2026 | $0 | -$18.32M | — | — | -$17.35M |
| Dec 31, 2025 | $0 | -$15.72M | — | — | -$13.25M |
| Sep 30, 2025 | $0 | -$14.26M | — | — | -$10.86M |
| Jun 30, 2025 | $0 | -$19.88M | — | — | -$11.83M |
| Mar 31, 2025 | $0 | -$16.63M | — | — | -$13.23M |
| Dec 31, 2024 | $0 | -$15.03M | — | — | -$9.16M |
| Sep 30, 2024 | $0 | -$10.48M | — | — | -$11.1M |
Reported figures can reflect company reporting conventions, restatements, or sector-specific accounting. Verify against filings before relying on a valuation comparison.
Recent CMPX news
All market newsNo ticker-linked stories are in the current archive.